Annual SG&A
$39.84 M
+$33.45 M+523.12%
31 December 2023
Summary:
Barinthus Biotherapeutics annual selling, general & administrative expenses is currently $39.84 million, with the most recent change of +$33.45 million (+523.12%) on 31 December 2023. During the last 3 years, it has risen by +$29.36 million (+280.17%). BRNS annual SG&A is now at all-time high.BRNS Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$13.42 M
+$6.22 M+86.36%
30 September 2024
Summary:
Barinthus Biotherapeutics quarterly selling, general & administrative expenses is currently $13.42 million, with the most recent change of +$6.22 million (+86.36%) on 30 September 2024. Over the past year, it has increased by +$12.46 million (+1296.46%). BRNS quarterly SG&A is now -30.70% below its all-time high of $19.36 million, reached on 31 December 2022.BRNS Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$794.80 M
-$57.83 M-7.85%
30 September 2024
Summary:
Barinthus Biotherapeutics TTM selling, general & administrative expenses is currently -$794.80 million, with the most recent change of -$57.83 million (-7.85%) on 30 September 2024. Over the past year, it has dropped by -$840.39 million (-1843.29%). BRNS TTM SG&A is now -1277.00% below its all-time high of $45.59 million, reached on 30 September 2023.BRNS TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BRNS Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +523.1% | +1296.5% | -1843.3% |
| 3 y3 years | +280.2% | +37.1% | -3264.3% |
| 5 y5 years | - | - | - |
BRNS Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +523.1% | -30.7% | +224.1% | -153.8% | at low |
| 5 y | 5 years | at high | +523.1% | -30.7% | +224.1% | -1277.0% | at low |
| alltime | all time | at high | +523.1% | -30.7% | +224.1% | -1277.0% | at low |
Barinthus Biotherapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $13.42 M(+86.4%) | $40.23 M(+44.9%) |
| June 2024 | - | $7.20 M(+20.1%) | $27.77 M(-17.6%) |
| Mar 2024 | - | $5.99 M(-56.0%) | $33.70 M(-15.4%) |
| Dec 2023 | $39.84 M(+523.1%) | $13.62 M(+1316.8%) | $39.84 M(-12.6%) |
| Sept 2023 | - | $961.00 K(-92.7%) | $45.59 M(+34.8%) |
| June 2023 | - | $13.13 M(+8.2%) | $33.82 M(+63.5%) |
| Mar 2023 | - | $12.14 M(-37.3%) | $20.69 M(+69.4%) |
| Dec 2022 | $6.39 M | $19.36 M(-279.1%) | $12.21 M(+363.7%) |
| Sept 2022 | - | -$10.81 M(-395.2%) | $2.63 M(-90.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $3.66 M(-62.6%) | $27.00 M(+7.5%) |
| Dec 2021 | $25.12 M(+139.7%) | - | - |
| Dec 2021 | - | $9.79 M(+726.5%) | $25.12 M(+10.4%) |
| Sept 2021 | - | $1.18 M(-90.4%) | $22.75 M(+0.9%) |
| June 2021 | - | $12.37 M(+596.2%) | $22.55 M(+102.3%) |
| Mar 2021 | - | $1.78 M(-76.1%) | $11.14 M(+6.3%) |
| Dec 2020 | $10.48 M | $7.42 M(+659.6%) | $10.48 M(+242.6%) |
| Sept 2020 | - | $977.00 K(+0.7%) | $3.06 M(+46.9%) |
| June 2020 | - | $970.00 K(-12.8%) | $2.08 M(+87.2%) |
| Mar 2020 | - | $1.11 M | $1.11 M |
FAQ
- What is Barinthus Biotherapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Barinthus Biotherapeutics?
- What is Barinthus Biotherapeutics annual SG&A year-on-year change?
- What is Barinthus Biotherapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Barinthus Biotherapeutics?
- What is Barinthus Biotherapeutics quarterly SG&A year-on-year change?
- What is Barinthus Biotherapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Barinthus Biotherapeutics?
- What is Barinthus Biotherapeutics TTM SG&A year-on-year change?
What is Barinthus Biotherapeutics annual selling, general & administrative expenses?
The current annual SG&A of BRNS is $39.84 M
What is the all time high annual SG&A for Barinthus Biotherapeutics?
Barinthus Biotherapeutics all-time high annual selling, general & administrative expenses is $39.84 M
What is Barinthus Biotherapeutics annual SG&A year-on-year change?
Over the past year, BRNS annual selling, general & administrative expenses has changed by +$33.45 M (+523.12%)
What is Barinthus Biotherapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of BRNS is $13.42 M
What is the all time high quarterly SG&A for Barinthus Biotherapeutics?
Barinthus Biotherapeutics all-time high quarterly selling, general & administrative expenses is $19.36 M
What is Barinthus Biotherapeutics quarterly SG&A year-on-year change?
Over the past year, BRNS quarterly selling, general & administrative expenses has changed by +$12.46 M (+1296.46%)
What is Barinthus Biotherapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of BRNS is -$794.80 M
What is the all time high TTM SG&A for Barinthus Biotherapeutics?
Barinthus Biotherapeutics all-time high TTM selling, general & administrative expenses is $45.59 M
What is Barinthus Biotherapeutics TTM SG&A year-on-year change?
Over the past year, BRNS TTM selling, general & administrative expenses has changed by -$840.39 M (-1843.29%)